Half Year Update

Allergy Therapeutics PLC – Half-year Report

Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy immunotherapy, today announces its unaudited interim results for the six months ended 31 December 2019....

Read More

PCI-PAL PLC – Half-year Report

PCI-PAL PLC (AIM: PCIP), the global provider of secure payment solutions, is pleased to announce its unaudited interim results for the six months to 31 December 2019....

Read More

Renalytix AI PLC – Half-year Report

Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces its unaudited interim results for the six months ended 31 December 2019,...

Read More

Craneware plc – Half-year Report

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces its unaudited results for the six months ended 31 December 2019....

Read More

Northamber PLC – Half-year Report

It is pleasing to be able to report that we have seen revenues increase in the first half from £24.2 million to £26.3 million for the comparative period last year...

Read More

Netcall PLC – Half-year Report

Netcall plc (AIM: NET), the leading provider of Low-code and customer engagement software, today announces its unaudited interim results for the six months ended 31 December 2019....

Read More

Tristel PLC – Half-year Report

Tristel plc (AIM: TSTL), the manufacturer of infection prevention and contamination control products utilising proprietary chlorine dioxide chemistry, announces its interim results for the six months ended 31 December 2019,...

Read More